Literature DB >> 7520448

Induction of tyrosine phosphorylation during ICAM-3 and LFA-1-mediated intercellular adhesion, and its regulation by the CD45 tyrosine phosphatase.

A G Arroyo1, M R Campanero, P Sánchez-Mateos, J M Zapata, M A Ursa, M A del Pozo, F Sánchez-Madrid.   

Abstract

Intercellular adhesion molecule (ICAM)-3, a recently described counter-receptor for the lymphocyte function-associated antigen (LFA)-1 integrin, appears to play an important role in the initial phase of immune response. We have previously described the involvement of ICAM-3 in the regulation of LFA-1/ICAM-1-dependent cell-cell interaction of T lymphoblasts. In this study, we further investigated the functional role of ICAM-3 in other leukocyte cell-cell interactions as well as the molecular mechanisms regulating these processes. We have found that ICAM-3 is also able to mediate LFA-1/ICAM-1-independent cell aggregation of the leukemic JM T cell line and the LFA-1/CD18-deficient HAFSA B cell line. The ICAM-3-induced cell aggregation of JM and HAFSA cells was not affected by the addition of blocking mAb specific for a number of cell adhesion molecules such as CD1 1a/CD18, ICAM-1 (CD54), CD2, LFA-3 (CD58), very late antigen alpha 4 (CD49d), and very late antigen beta 1 (CD29). Interestingly, some mAb against the leukocyte tyrosine phosphatase CD45 were able to inhibit this interaction. Moreover, they also prevented the aggregation induced on JM T cells by the proaggregatory anti-LFA-1 alpha NKI-L16 mAb. In addition, inhibitors of tyrosine kinase activity also abolished ICAM-3 and LFA-1-mediated cell aggregation. The induction of tyrosine phosphorylation through ICAM-3 and LFA-1 antigens was studied by immunofluorescence, and it was found that tyrosine-phosphorylated proteins were preferentially located at intercellular boundaries upon the induction of cell aggregation by either anti-ICAM-3 or anti-LFA-1 alpha mAb. Western blot analysis revealed that the engagement of ICAM-3 or LFA-1 with activating mAb enhanced tyrosine phosphorylation of polypeptides of 125, 70, and 38 kD on JM cells. This phenomenon was inhibited by preincubation of JM cells with those anti-CD45 mAb that prevented cell aggregation. Altogether these results indicate that CD45 tyrosine phosphatase plays a relevant role in the regulation of both intracellular signaling and cell adhesion induced through ICAM-3 and beta 2 integrins.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7520448      PMCID: PMC2120152          DOI: 10.1083/jcb.126.5.1277

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  64 in total

1.  Signal transduction through the CD4 receptor involves the activation of the internal membrane tyrosine-protein kinase p56lck.

Authors:  A Veillette; M A Bookman; E M Horak; L E Samelson; J B Bolen
Journal:  Nature       Date:  1989-03-16       Impact factor: 49.962

2.  CD45-mediated regulation of LFA1 function in human natural killer cells. Anti-CD45 monoclonal antibodies inhibit the calcium mobilization induced via LFA1 molecules.

Authors:  A Poggi; R Pardi; N Pella; L Morelli; S Sivori; M Vitale; V Revello; A Moretta; L Moretta
Journal:  Eur J Immunol       Date:  1993-10       Impact factor: 5.532

3.  Co-clustering of beta 1 integrins, cytoskeletal proteins, and tyrosine-phosphorylated substrates during integrin-mediated leukocyte aggregation.

Authors:  P Sánchez-Mateos; M R Campanero; M A Balboa; F Sánchez-Madrid
Journal:  J Immunol       Date:  1993-10-01       Impact factor: 5.422

4.  Distribution of ICAM-3-bearing cells in normal human tissues. Expression of a novel counter-receptor for LFA-1 in epidermal Langerhans cells.

Authors:  A Acevedo; M A del Pozo; A G Arroyo; P Sánchez-Mateos; R González-Amaro; F Sánchez-Madrid
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

5.  ICAM-3, the third LFA-1 counterreceptor, is a co-stimulatory molecule for both resting and activated T lymphocytes.

Authors:  T Hernandez-Caselles; G Rubio; M R Campanero; M A del Pozo; M Muro; F Sanchez-Madrid; P Aparicio
Journal:  Eur J Immunol       Date:  1993-11       Impact factor: 5.532

6.  Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3.

Authors:  F Sanchez-Madrid; A M Krensky; C F Ware; E Robbins; J L Strominger; S J Burakoff; T A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

7.  Human CD45RC specificity. A novel marker for T cells at different maturation and activation stages.

Authors:  J M Zapata; R Pulido; A Acevedo; F Sánchez-Madrid; M O de Landázuri
Journal:  J Immunol       Date:  1994-04-15       Impact factor: 5.422

8.  Characterization of two new CD18 alleles causing severe leukocyte adhesion deficiency.

Authors:  C López Rodríguez; A Nueda; B Grospierre; F Sánchez-Madrid; A Fischer; T A Springer; A L Corbí
Journal:  Eur J Immunol       Date:  1993-11       Impact factor: 5.532

9.  ICAM-3 interacts with LFA-1 and regulates the LFA-1/ICAM-1 cell adhesion pathway.

Authors:  M R Campanero; M A del Pozo; A G Arroyo; P Sánchez-Mateos; T Hernández-Caselles; A Craig; R Pulido; F Sánchez-Madrid
Journal:  J Cell Biol       Date:  1993-11       Impact factor: 10.539

10.  Beta 2 integrin engagement triggers actin polymerization and phosphatidylinositol trisphosphate formation in non-adherent human neutrophils.

Authors:  R Löfgren; J Ng-Sikorski; A Sjölander; T Andersson
Journal:  J Cell Biol       Date:  1993-12       Impact factor: 10.539

View more
  20 in total

1.  Inhibition of tyrosine kinases blocks adhesion-induced T-cell coactivation without interfering with T-cell adhesion to endothelial cell-surface ligands.

Authors:  Dawn M Nowlin; Pina M Cardarelli; Lynn Young; Jason Mah; Katherine A Felts; Marian Mastrangelo; Ronald R Cobb
Journal:  Inflammation       Date:  2002-02       Impact factor: 4.092

2.  Integrin CD11a cytoplasmic tail interacts with the CD45 membrane-proximal protein tyrosine phosphatase domain 1.

Authors:  Xin Geng; Ren-Hong Tang; S K Alex Law; Suet-Mien Tan
Journal:  Immunology       Date:  2005-07       Impact factor: 7.397

Review 3.  Regulation of cell signaling by the protein tyrosine phosphatases, CD45 and SHP-1.

Authors:  T Ulyanova; J Blasioli; M L Thomas
Journal:  Immunol Res       Date:  1997-02       Impact factor: 2.829

Review 4.  The intercellular adhesion molecule (ICAM) family of proteins. New members and novel functions.

Authors:  J S Hayflick; P Kilgannon; W M Gallatin
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

5.  The immune dysregulatory compound mercuric chloride induces integrin-mediated T-lymphocyte adhesion.

Authors:  A Roos; M Neeft; L Engelen; E J Schilder-Tol; U Kunzendorf; J J Weening; J Aten
Journal:  Immunology       Date:  2001-01       Impact factor: 7.397

6.  Dual role of the actin cytoskeleton in regulating cell adhesion mediated by the integrin lymphocyte function-associated molecule-1.

Authors:  M Lub; Y van Kooyk; S J van Vliet; C G Figdor
Journal:  Mol Biol Cell       Date:  1997-02       Impact factor: 4.138

7.  The interaction of activated integrin lymphocyte function-associated antigen 1 with ligand intercellular adhesion molecule 1 induces activation and redistribution of focal adhesion kinase and proline-rich tyrosine kinase 2 in T lymphocytes.

Authors:  J L Rodríguez-Fernández; M Gómez; A Luque; N Hogg; F Sánchez-Madrid; C Cabañas
Journal:  Mol Biol Cell       Date:  1999-06       Impact factor: 4.138

8.  Mechanisms of integrin-mediated calcium signaling in MDCK cells: regulation of adhesion by IP3- and store-independent calcium influx.

Authors:  M D Sjaastad; R S Lewis; W J Nelson
Journal:  Mol Biol Cell       Date:  1996-07       Impact factor: 4.138

9.  Fibronectin modulates the effects of HIV-1 Tat on the growth of murine Kaposi's sarcoma-like cells through the down-regulation of tyrosine phosphorylation.

Authors:  Z Wu; U Cavallaro; P C Marchisio; M R Soria; J A Maier
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

Review 10.  Intercellular adhesion molecule-1.

Authors:  A van de Stolpe; P T van der Saag
Journal:  J Mol Med (Berl)       Date:  1996-01       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.